Jackson-Lewis V - Search Results

1

Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.

Pennathur S, Jackson-Lewis V, Przedborski S, Heinecke JW. Pennathur S, et al. J Biol Chem. 1999 Dec 3;274(49):34621-8. doi: 10.1074/jbc.274.49.34621. J Biol Chem. 1999. PMID: 10574926 Free article.

2

Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.

Choi DK, Pennathur S, Perier C, Tieu K, Teismann P, Wu DC, Jackson-Lewis V, Vila M, Vonsattel JP, Heinecke JW, Przedborski S. Choi DK, et al. J Neurosci. 2005 Jul 13;25(28):6594-600. doi: 10.1523/JNEUROSCI.0970-05.2005. J Neurosci. 2005. PMID: 16014720 Free PMC article.

3

Protocol for the MPTP mouse model of Parkinson's disease.

Jackson-Lewis V, Przedborski S. Jackson-Lewis V, et al. Nat Protoc. 2007;2(1):141-51. doi: 10.1038/nprot.2006.342. Nat Protoc. 2007. PMID: 17401348

4

Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Ara J, et al. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7659-63. doi: 10.1073/pnas.95.13.7659. Proc Natl Acad Sci U S A. 1998. PMID: 9636206 Free PMC article.

5

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos H. Przedborski S, et al. J Neurochem. 2001 Jan;76(2):637-40. doi: 10.1046/j.1471-4159.2001.00174.x. J Neurochem. 2001. PMID: 11208927 Free article.

6

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S. Vila M, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2837-42. doi: 10.1073/pnas.051633998. Epub 2001 Feb 13. Proc Natl Acad Sci U S A. 2001. PMID: 11226327 Free PMC article.

7

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. Wu DC, et al. J Neurosci. 2002 Mar 1;22(5):1763-71. doi: 10.1523/JNEUROSCI.22-05-01763.2002. J Neurosci. 2002. PMID: 11880505 Free PMC article.

8

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S. Wu DC, et al. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6145-50. doi: 10.1073/pnas.0937239100. Epub 2003 Apr 29. Proc Natl Acad Sci U S A. 2003. PMID: 12721370 Free PMC article.

9

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL. Przedborski S, et al. J Neurosci. 1992 May;12(5):1658-67. doi: 10.1523/JNEUROSCI.12-05-01658.1992. J Neurosci. 1992. PMID: 1578260 Free PMC article.

10

Mechanisms of MPTP toxicity.

Przedborski S, Jackson-Lewis V. Przedborski S, et al. Mov Disord. 1998;13 Suppl 1:35-8. Mov Disord. 1998. PMID: 9613716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters